Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
Clinical trial NCT01270945 · COMPLETED
Trial details
- NCT number
- NCT01270945
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-30
- Primary completion
- 2013-09-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.